Find News

Filter articles

Showing 2831 to 2840 of 2887 results

Teva and Sun stung by $2 billion settlement


Generic drug-makers Teva Pharmaceutical and Sun Pharmaceutical have agreed to pay a combined $2.15 billion to settle a patent infringement case over Pfizer’s heartburn drug Protonix.

US Supreme Court strikes Myriad blow


The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.

IPAB sets aside Sutent patent rejection


India’s Intellectual Property Appellate Board has set aside a decision revoking a Pfizer-licensed patent directed to cancer drug Sutent.

Shire settles with Teva over ADHD drug


Drug-maker Teva must wait until 2015 before selling generic versions of Shire’s Intuniv product, according to a patent settlement between the companies.

Takeda sues generics over heartburn drug


Japanese pharma company Takeda has sued generic drug-makers Impax and Sandoz for allegedly infringing a patent directed to its anti-heartburn drug Dexilant.

Amgen and Astellas join forces in Japan

Japan, US30-05-2013

California-based biotechnology company Amgen has entered into a long-term partnership with Japanese pharmaceutical company Astellas Pharmas Inc to provide new medicines in Japan.

Patents covering IVF test spark row


Members of the scientific community have blasted Stanford University and US biotechnology company Auxogyn for their involvement in patenting a test designed to increase the success of in vitro fertilisation (IVF).

Hi-tech and life sciences dominate at EPO awards


The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

WHO issues IP warning over MERS virus


The World Health Organization has warned that “no IP will stand in the way of public health actions” amid the spreading of a deadly global virus.

Actavis to buy Warner Chilcott

Ireland, US22-05-2013

Actavis announced on May 20 it will acquire specialty pharmaceutical company Warner Chilcott plc in a deal worth an estimated $5 billion.

Showing 2831 to 2840 of 2887 results